Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes

References

• Food and Drug Administration (FDA). Real-world evidence. 2023 [cited 26 October 2023]; Available from: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). NICE real-world evidence framework. 2022 [cited April 2023]; Available from: https://www.nice.org.uk/corporate/ecd9/chapter/introduction-to-real-world-evidence-in-nice-decision-making.
   Google Scholar
• Food and Drug Administration (FDA). Framework for FDA’s Real-World Evidence Program. 2018 [cited June 2020]; Available from: https://www.fda.gov/media/120060/download.
   Google Scholar
• Food and Drug Administration (FDA). Use of electronic health record data in clinical investigations guidance for industry. 2018 [cited June 2020]; Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-health-record-data-clinical-investigations-guidance-industry.
   Google Scholar
• Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):e213. doi: 10.3346/jkms.2018.33.e213.
   PubMed Web of Science ®Google Scholar
• Tan YY, Papez V, Chang WH, et al. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England. Lancet Healthy Longev. 2022;3(10):e674–e89. doi: 10.1016/S2666-7568(22)00186-6.
   PubMedGoogle Scholar
• Schroeder M, Lim YMF, Savarese G, et al. Sex differences in the generalizability of randomized clinical trials in heart failure with reduced ejection fraction. Eur J Heart Fail. 2023;25(6):912–921. doi: 10.1002/ejhf.2868.
   PubMed Web of Science ®Google Scholar
• Berger M, Daniel G, Frank K, et al. A framework for regulatory use of real-world evidence 2017 [cited 22 May 2023]; Available from: https://healthpolicy.duke.edu/sites/default/files/2020-08/rwe_white_paper_2017.09.06.pdf.
   Google Scholar
• Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: disease-Specific programmes – a means to understand. Curr Med Res Opin. 2008;24(11):3063–3072. doi: 10.1185/03007990802457040.
   PubMed Web of Science ®Google Scholar
• Babineaux SM, Curtis B, Holbrook T, et al. Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the disease specific programme. BMJ Open. 2016;6(8):e010352. doi: 10.1136/bmjopen-2015-010352.
   PubMed Web of Science ®Google Scholar
• Higgins V, Piercy J, Roughley A, et al. Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015. Diabetes Metab Syndr Obes. 2016;9:371–380. doi: 10.2147/DMSO.S120101.
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Summary of the HIPAA privacy rule. 2003;2020(May).
   Google Scholar
• Health Information Technology (HITECH). Health Information Technology Act. 2009;2020(May).
   Google Scholar
• European Pharmaceutical Market Research Association (EphMRA). Code of Conduct. 2021 [cited January 2023]; Available from: https://www.ephmra.org/sites/default/files/2022-03/2021%2520EPHMRA%2520Code%2520of%2520Conduct%25202.11.21.pdf.
   Google Scholar
• International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 2022–2023 Top 10 HEOR trends. 2022 cited January 2023]; Available from: https://www.ispor.org/docs/default-source/ispor-good-practices-for-outcomes-research-index/ispor_top10-2022-2023_online.pdf?sfvrsn=61a9ec28_2.
   Google Scholar
• Hall JP, Chang J, Moon R, et al. Real-world treatment patterns in patients with advanced (stage III-IV) ovarian cancer in the USA and Europe. Future Oncol. 2020;16(15):1013–1030. doi: 10.2217/fon-2020-0083.
   PubMed Web of Science ®Google Scholar
• Rane PB, Patel J, Harrison DJ, et al. Patient characteristics and real-world treatment patterns among early users of PCSK9 inhibitors. Am J Cardiovasc Drugs. 2018;18(2):103–108. doi: 10.1007/s40256-017-0246-z.
   PubMed Web of Science ®Google Scholar
• Patel V, Horn EJ, Lobosco SJ, et al. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008;58(6):964–969. doi: 10.1016/j.jaad.2008.02.048.
   PubMed Web of Science ®Google Scholar
• Pillas D, Klein A, Gasalla T, et al. The burden of progressive supranuclear palsy on patients, caregivers, and healthcare systems by PSP phenotype: a cross-sectional study. Front Neurol. 2022;13:821570. doi: 10.3389/fneur.2022.821570.
   PubMed Web of Science ®Google Scholar
• Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. 2013;81(2):288–293. doi: 10.1016/j.lungcan.2013.03.008.
   PubMed Web of Science ®Google Scholar
• Wei W, Anderson P, Gadkari A, et al. Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis. J Dermatol. 2018;45(2):150–157. doi: 10.1111/1346-8138.14116.
   PubMed Web of Science ®Google Scholar
• Sadosky AB, Bushmakin AG, Cappelleri JC, et al. Relationship between patient-reported disease severity in osteoarthritis and self-reported pain, function and work productivity. Arthritis Res Ther. 2010;12(4):R162. doi: 10.1186/ar3121.
   PubMed Web of Science ®Google Scholar
• Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;85(62 Suppl):17–25.
   Web of Science ®Google Scholar
• Christophers E, Barker JN, Griffiths CE, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European Dermatology Clinics. J Eur Acad Dermatol Venereol. 2010;24(5):548–554. doi: 10.1111/j.1468-3083.2009.03463.x.
   PubMed Web of Science ®Google Scholar
• Ford JH, Jackson J, Milligan G, et al. A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache. 2017;57(10):1532–1544. doi: 10.1111/head.13202.
   PubMed Web of Science ®Google Scholar
• Small M, Vickers A, Anderson P, et al. The patient-physician partnership in asthma: real-world observations associated with clinical and patient-reported outcomes. Adv Therapy. 2010;27(9):591–599. doi: 10.1007/s12325-010-0054-1.
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Skorvanek M, Henriksen T, et al. Impact of advanced Parkinson’s disease on caregivers: an international real-world study. J Neurol. 2023;270(4):2162–2173. doi: 10.1007/s00415-022-11546-5.
   PubMed Web of Science ®Google Scholar
• Vilsboll AW, Anderson P, Piercy J, et al. Extent and impact of inadequate disease control in US adults with a history of moderate to severe atopic dermatitis following introduction of new treatments. Dermatol Ther (Heidelb). 2021;11(2):475–486. doi: 10.1007/s13555-021-00488-x.
   PubMed Web of Science ®Google Scholar
• Anstee QM, Hallsworth K, Lynch N, et al. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions. JHEP Rep. 2022;4(1):100411. doi: 10.1016/j.jhepr.2021.100411.
   PubMedGoogle Scholar
• Small M, Anderson P, Vickers A, et al. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes. Adv Therapy. 2011;28(3):202–212. doi: 10.1007/s12325-010-0108-4.
   PubMed Web of Science ®Google Scholar
• Lautsch D, Boggs R, Wang T, et al. Individualized HbA(1c) goals, and patient awareness and attainment of goals in type 2 diabetes mellitus: a real-world multinational survey. Adv Ther. 2022;39(2):1016–1032. doi: 10.1007/s12325-021-01985-3.
   PubMed Web of Science ®Google Scholar
• Malaty IA, Martinez-Martin P, Chaudhuri KR, et al. Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries. BMC Neurol. 2022;22(1):35. doi: 10.1186/s12883-022-02560-1.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma. 2023 [cited September 2023]; Available from: https://www.nice.org.uk/guidance/TA894.
   Google Scholar
• European Medicines Agency (EMA). Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making. 2022; Available from: https://www.ema.europa.eu/en/news/global-regulators-call-international-collaboration-integrate-real-world-evidence-regulatory-decision#:∼:text=EMA%20has%20endorsed%20a%20joint,Medicines%20Regulatory%20Authorities%20(ICMRA).
   Google Scholar
• Food and Drug Administration (FDA). 21st Century Cures Act. 2016 [cited 08 June 2020]; Available from: https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act.
   Google Scholar
• Khosla S, White R, Medina J, et al. Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? F1000Res. 2018;7:111.
   PubMedGoogle Scholar
• Conaghan PG, Abraham L, Viktrup L, et al. Impact of osteoarthritis disease severity on treatment patterns and healthcare resource use: analysis of real-world data. Scand J Rheumatol. 2023;52(4):353–363. doi: 10.1080/03009742.2022.2058168.
   PubMed Web of Science ®Google Scholar
• Fitzgerald HM, Shepherd J, Bailey H, et al. Treatment goals in schizophrenia: a real-world survey of patients, psychiatrists, and caregivers in the United States, with an analysis of current treatment (long-acting injectable vs oral antipsychotics) and goal selection. NDT. 2021;ume 17:3215–3228. doi: 10.2147/NDT.S330936.
   Web of Science ®Google Scholar
• Black CM, Ritchie CW, Khandker RK, et al. Non-professional caregiver burden is associated with the severity of patients’ cognitive impairment. PLoS ONE. 2018;13(12):e0204110. doi: 10.1371/journal.pone.0204110.
   PubMed Web of Science ®Google Scholar
• Lahoz R, Proudfoot C, Fonseca AF, et al. Caregivers of patients with heart failure: burden and the determinants of Health-Related quality of life. PPA. 2021;ume 15:1153–1164. doi: 10.2147/PPA.S297816.
   Web of Science ®Google Scholar
• Chhabra A, Spurden D, Fogarty PF, et al. Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia a and B. Blood Coagul Fibrinolysis. 2020;31(3):186–192. doi: 10.1097/MBC.0000000000000885.
   PubMed Web of Science ®Google Scholar
• Sullivan E, Piercy J, Waller J, et al. Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn’s disease across Germany. PLoS ONE. 2017;12(4):e0175826. doi: 10.1371/journal.pone.0175826.
   PubMed Web of Science ®Google Scholar
• Neumann PJ, Garrison LP, Willke RJ. The history and future of the "ISPOR value flower": addressing limitations of conventional cost-effectiveness analysis. Value Health. 2022;25(4):558–565. doi: 10.1016/j.jval.2022.01.010.
   PubMed Web of Science ®Google Scholar
• Lakdawalla DN, Doshi JA, Garrison LP, Jr., et al. Defining elements of value in health care – a health economics approach: an ISPOR special task force report [3]. Value Health. 2018;21(2):131–139. doi: 10.1016/j.jval.2017.12.007.
   PubMed Web of Science ®Google Scholar
• Richesson R, Vehik K. Patient registries: utility, validity and inference. Adv Exp Med Biol. 2010;686:87–104.
   PubMed Web of Science ®Google Scholar
• Tan MH, Thomas M, MacEachern MP. Using registries to recruit subjects for clinical trials. Contemp Clin Trials. 2015;41:31–38. doi: 10.1016/j.cct.2014.12.012.
   PubMed Web of Science ®Google Scholar
• Wirta SB, Balas B, Proenca CC, et al. Perceptions of heart failure symptoms, disease severity, treatment decision-making, and side effects by patients and cardiologists: a multinational survey in a cardiology setting. TCRM. 2018;ume 14:2265–2272. doi: 10.2147/TCRM.S183200.
   Web of Science ®Google Scholar
• Soriano ER, Zazzetti F, Alves Pereira I, et al. Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America. Clin Rheumatol. 2020;39(6):1859–1869. doi: 10.1007/s10067-019-04870-1.
   PubMed Web of Science ®Google Scholar
• Sikirica MV, Martin AA, Wood R, et al. Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes. DMSO. 2017;ume 10:403–412. doi: 10.2147/DMSO.S141235.
   Web of Science ®Google Scholar
• Wang C, Aranishi T, Reed C, et al. Impact of patient and physician disconnect on satisfaction with treatment for atopic dermatitis in Japan. Dermatol Ther (Heidelb). 2023;13(2):505–522. doi: 10.1007/s13555-022-00866-z.
   PubMed Web of Science ®Google Scholar
• Hubbard TE, Paradis R. Real-World evidence: a new era for health care innovation the network for excellence in health innovation. 2015.
   Google Scholar
• Vestbo J, Vogelmeier C, Small M, et al. Understanding the GOLD 2011 strategy as applied to a real-world COPD population. Respir Med. 2014;108(5):729–736.
   PubMed Web of Science ®Google Scholar
• Smid DE, Franssen FME, Gonik M, et al. Redefining cut-points for high symptom burden of the global initiative for chronic obstructive lung disease classification in 18,577 patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18(12):1097 e11–97 e24.
   PubMed Web of Science ®Google Scholar
• Black CM, Woodward M, Ambegaonkar BM, et al. Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from Australia. Int Psychogeriatr. 2020;32(5):601–610. doi: 10.1017/S1041610219001856.
   PubMed Web of Science ®Google Scholar
• Horvath Walsh LE, Rider A, Piercy J, et al. Real-world impact of physician and patient discordance on health-related quality of life in US patients with acute myeloid leukemia. Oncol Ther. 2019;7(1):67–81. doi: 10.1007/s40487-019-0094-x.
   PubMed Web of Science ®Google Scholar
• Korman NJ, Zhao Y, Pike J, et al. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Dermatol Online J. 2016;22(7).
   Google Scholar
• Wei W, Anderson P, Gadkari A, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18(6):825–835. doi: 10.1007/s40257-017-0284-y.
   PubMed Web of Science ®Google Scholar
• Amin AN, Ganapathy V, Roughley A, et al. Confidence in correct inhaler technique and its association with treatment adherence and health status among US patients with chronic obstructive pulmonary disease. PPA. 2017;ume 11:1205–1212. doi: 10.2147/PPA.S140139.
   Web of Science ®Google Scholar
• Chrystyn H, Small M, Milligan G, et al. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108(2):358–365. doi: 10.1016/j.rmed.2013.09.021.
   PubMed Web of Science ®Google Scholar
• Waller J, Sullivan E, Piercy J, et al. Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany. PPA. 2017;ume 11:519–530. doi: 10.2147/PPA.S129333.
   Web of Science ®Google Scholar
• Benford M, Milligan G, Pike J, et al. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance. Adv Ther. 2012;29(1):26–40. doi: 10.1007/s12325-011-0096-z.
   PubMed Web of Science ®Google Scholar
• Cook NS, Criner GJ, Burgel PR, et al. People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference study. ERJ Open Res. 2022;8(2):00686-2021. doi: 10.1183/23120541.00686-2021.
   PubMedGoogle Scholar
• Pike J, Dong Y, Piercy J, et al. Cross-walk of the assessment of spondyloarthritis international society health index and ankylosing spondylitis quality of life scores in ankylosing spondylitis and non-radiographic axial spondyloarthritis patients. Rheumatol Ther. 2021;8(2):849–862. doi: 10.1007/s40744-021-00306-y.
   PubMed Web of Science ®Google Scholar
• Kay S, Tolley K, Colayco D, et al. Mapping EQ-5D utility scores from the incontinence quality of life questionnaire among patients with neurogenic and idiopathic overactive bladder. Value Health. 2013;16(2):394–402. doi: 10.1016/j.jval.2012.12.005.
   PubMed Web of Science ®Google Scholar
• Fishman J, Higgins V, Piercy J, et al. Cross-walk of the chronic liver disease questionnaire for nonalcoholic steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH. Health Qual Life Outcomes. 2023; Oct 1421(1):113.
   PubMed Web of Science ®Google Scholar
• Andersson F, Anderson P, Holm-Larsen T, et al. Assessing the impact of nocturia on health-related quality-of-life and utility: results of an observational survey in adults. J Med Econ. 2016;19(12):1200–1206. doi: 10.1080/13696998.2016.1211136.
   PubMed Web of Science ®Google Scholar
• Leith A, Ribbands A, Kim J, et al. Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan. Future Oncol. 2022;18(8):937–951. doi: 10.2217/fon-2021-1113.
   PubMed Web of Science ®Google Scholar
• Gairy K, Knight C, Anthony P, et al. Burden of illness among subgroups of patients with primary Sjogren’s syndrome and systemic involvement. Rheumatology (Oxford). 2021;60(4):1871–1881. doi: 10.1093/rheumatology/keaa508.
   PubMed Web of Science ®Google Scholar
• Gossec L, Walsh JA, Michaud K, et al. Women with psoriatic arthritis experience higher disease burden than men: findings from a Real-World survey in the United States and Europe. J Rheumatol. 2023;50(2):192–196. doi: 10.3899/jrheum.220154.
   PubMed Web of Science ®Google Scholar
• Ueda K, Ye W, Lombard L, et al. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain. 2019;20(1):68. doi: 10.1186/s10194-019-1012-1.
   PubMed Web of Science ®Google Scholar